Latest Articles
The Impact of the CMS Home Health and Hospice Moratorium on M&A Activity and Valuations
In May 2026, the Centers for Medicare & Medicaid Services (CMS) announced a nationwide six-month moratorium on new Medicare enrollments for home health and hospice providers. The a [...]
Stoneridge Partners, Joe Lynch and Tom Lillis, served as sell-side M&A advisors to HCF Management in connection with their partnership of Heritage Home Health Care and Legacy Hospice with Advanced Home Health and Hospice
June 4, 2026, Ohio - Stoneridge Partners (Stoneridge), a national healthcare mergers and acquisitions advisory and strategic consulting firm, is pleased to announce that they provided [...]
The Non-Skilled Advantage: Private-Pay Valuation Trends
The demand for aging-in-place solutions continues to soar as we move through 2026. While Medicare-certified agencies often grab the headlines, a quiet powerhouse dominates the market: [...]
Stoneridge Partners, Joe Lynch and Tom Lillis, provided sell-side M&A advisory services to HomeCourt Home Care in their transaction with Addus HomeCare Corporation
May 8, 2026, Indiana - Stoneridge Partners (Stoneridge), a national healthcare mergers and acquisitions advisory and strategic consulting firm, is pleased to announce that they provid [...]
Selling Your Hospice Agency: Operational Metrics/CAP & Valuation
Stepping away from the agency you built takes careful thought and precise timing. You have dedicated your career to providing compassionate end-of-life care, and now as you look towar [...]
The Pre-Sale Due Diligence Checklist for Healthcare Owners (2026 Edition)
The decision to exit your business is just the beginning of a complex, high-stakes journey. You have spent years building a successful agency, cultivating a reliable referral network, [...]

